Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The prognostic value of alpha-thymosins in breast cancer.
Tsitsilonis OE, Bekris E, Voutsas IF, Baxevanis CN, Markopoulos C, Papadopoulou SA, Kontzoglou K, Stoeva S, Gogas J, Voelter W, Papamichail M. Tsitsilonis OE, et al. Among authors: voutsas if. Anticancer Res. 1998 May-Jun;18(3A):1501-8. Anticancer Res. 1998. PMID: 9673361
Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice.
Baxevanis CN, Voutsas IF, Tsitsilonis OE, Tsiatas ML, Gritzapis AD, Papamichail M. Baxevanis CN, et al. Among authors: voutsas if. Eur J Immunol. 2000 Jul;30(7):1957-66. doi: 10.1002/1521-4141(200007)30:7<1957::AID-IMMU1957>3.0.CO;2-7. Eur J Immunol. 2000. PMID: 10940885 Free article.
The immunologically active site of prothymosin alpha is located at the carboxy-terminus of the polypeptide. Evaluation of its in vitro effects in cancer patients.
Skopeliti M, Voutsas IF, Klimentzou P, Tsiatas ML, Beck A, Bamias A, Moraki M, Livaniou E, Neagu M, Voelter W, Tsitsilonis OE. Skopeliti M, et al. Among authors: voutsas if. Cancer Immunol Immunother. 2006 Oct;55(10):1247-57. doi: 10.1007/s00262-005-0108-4. Epub 2006 Feb 2. Cancer Immunol Immunother. 2006. PMID: 16453152 Free PMC article.
Ii-Key/HER-2/neu(776-790) hybrid peptides induce more effective immunological responses over the native peptide in lymphocyte cultures from patients with HER-2/neu+ tumors.
Sotiriadou NN, Kallinteris NL, Gritzapis AD, Voutsas IF, Papamichail M, von Hofe E, Humphreys RE, Pavlis T, Perez SA, Baxevanis CN. Sotiriadou NN, et al. Among authors: voutsas if. Cancer Immunol Immunother. 2007 May;56(5):601-13. doi: 10.1007/s00262-006-0213-z. Epub 2006 Sep 8. Cancer Immunol Immunother. 2007. PMID: 16960693 Free PMC article.
36 results